Atossa Therapeutics ATOS
NASDAQ ATOS
$2.03 -0.11 (-5.14%)
At close: Nov 11, 2026 · 4:00 PM EST

Atossa Therapeutics (ATOS) Net Debt Issuances and Repayments (2009 - 2015)

Updated

Analysis

Atossa Therapeutics (ATOS) Net Debt Issuances and Repayments (2009 - 2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -5.28 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.28 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.48 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -682.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.91 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -87.00 Mn
10 Atossa Therapeutics 21.38 Mn -98.31 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 49,215.00
Dec 31, 2014 -98,481.00
Dec 31, 2012 -330,453.00
Sep 30, 2012 81,553.00
Mar 31, 2012 -756,178.00
Dec 31, 2011 -4,922.00
Apr 30, 2009 2,000.00
API Access

Atossa Therapeutics Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=ATOS&period=max&api_key=YOUR_API_KEY